A phase IV study of Apricity C.A.R.E. program for Cancer Adverse events RapidEvaluation to improve treatment outcomes of ethnic/racial minority non-small cell lung cancer (NSCLC) patients receiving immunotherapy
ApricityCare: Smartphone App Study for Patients with Non-Small Cell Lung Cancer (NSCLC)
Sponsor: Stand Up 2 Cancer
Enrolling: Male and Female Patients
IRB Number: AAAU2705
U.S. Govt. ID: NCT05812274
Contact: Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu
Additional Study Information: The therapy you are receiving for your cancer has known side effects. If those side effects are caught early, they may be less serious, easier to treat, and less likely to lead to discontinuation of your cancer therapy. Apricity Health has created the Apricity CARE program, which includes a smartphone app called ApricityCare for monitoring and reporting these side effects, and licensed nurses who can respond to you virtually to evaluate your side effects and communicate to your doctors without delay. The app also has education material to teach you about these side effects. You can also have your care takers to report the side effects using the ApricityCare app. Or you can call directly to the nurses by phone to report your side effects so they can be evaluated without delay. The purpose of this research study is to test how well this program works, and if patients like you find it easy to use for the purposes of reporting and learning about these side effects.
Brian Henick, MD
Do You Qualify?
Are you at least 18 years old? Yes No
Have you been diagnosed with Non-Small Cell Lung Cancer (NSCLC)? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Research Nurse Navigator